Iktos, a leader in Artificial Intelligence (AI) and Robotics applied to drug discovery, announced a landmark multi-targe...
The Australian government is investing $10.1 million to support the next generation of health and medical researche...
Pandorum Technologies, a clinical-stage regenerative medicine company building a next-generation platform for programmab...
Researchers from the Department of Bio and Brain Engineering at Korea Advanced Institute of Science and Technology (KAIS...
The Hong Kong Polytechnic University (PolyU) has developed an acid-resistant “ultra-stable mucus-inspired hydrogel...
Leading scientific organisations in Korea including the Korea Disease Control Agency (KDCA), International Vaccine Insti...
3D printed blood vessels on glass that mimic blood vessel anatomy and the fluid dynamics of blood flow could be an inval...
Vaxcellbio, a South Korea-based immuno-oncology company, has entered into a strategic Memorandum of Understanding (MoU) ...
Kaigene Inc., a US-based biotechnology startup pioneering next-generation antibody therapeutics for autoimmune disorders...
Parkinson’s disease is Singapore’s second most common neurodegenerative disorder, affecting about three in e...
Fujifilm Corporation has signed a joint research agreement with the National Cancer Center Japan, a Tokyo-based national...
China's Qyuns Therapeutics has entered into a global exclusive collaboration and license agreement with F. Hoffmann-La R...
Australia-based Myrio Therapeutics has announced a collaborative research partnership with the University of Pennsylvani...
China's Innovent Biologics has announced a strategic global collaboration with Japanese pharmaceutical firm Takeda to ad...
Siemens Healthineers and the National University Hospital (NUH) Singapore have announced a strategic research collaborat...
Professor Shawn Chen Xiaoyuan, Nasrat Muzayyin Professor in Medicine and Technology from the Department of Dia...
A Gastrointestinal (GI) consensus meeting in Malaysia brought together leading gastroenterology experts from across the ...
AuctuCel, a biotech spin-off from Singapore's A*STAR Bioprocessing Technology Institute (BTI), has officially launched w...
Global Engage presented 'The Discovery & Development Summit Asia 2025' a premier breakthrough event in Singapore on ...
Researchers at the Antimicrobial Resistance (AMR) interdisciplinary research group of the Singapore-MIT A...
Soft tissue deformation during body movement has long posed a challenge to achieving optimal garment fit and comfort, pa...
Targeted protein degraders (TPD) are rapidly moving from niche science to mainstream drug development, with few therapie...
Developing effective antiviral drugs against mosquito-borne viruses like dengue and Zika requires understanding the func...
Australia's University of Queensland (UQ) researchers have been the first in the world to successfully grow fully functi...
The Asia Bio Innovation Summit 2025, held in Singapore, emerged as a landmark event in the biopharmaceutical industry, f...
US-based startup Skyhawk Therapeutics, Inc., a leader in the discovery and development of small molecules that modulate ...
GC Biopharma, a South Korean biopharmaceutical company, has signed a Memorandum of Understanding (MoU) with the Thai Red...
Singapore's 65LAB has awarded US$1.5 million (approx. S$1.9 million) to Professor Enrico Petretto to advance a breakthro...
In celebration of the World Hepatitis Day (28 July), HCSA Community Services and Tan Tock Seng Hospital (TTSH), an ancho...
Life Biosciences, a US-based biotechnology company pioneering cellular rejuvenation therapies to reverse and prevent mul...
Alloy Therapeutics Co. has announced the signing of a Memorandum of Understanding (MoU) with the Kansai Startup Academia...
The Global Antibiotic Research & Development Partnership (GARDP) and Institute of Science Tokyo, in Japan, have sign...
365mc, South Korea's leading medical institution specialising in fat reduction treatments, and Israel-based Ra...
South Korea-based startup Illimis Therapeutics has announced the closing of 58 billion KRW ($42 million) Series B financ...
The Department of Health – Abu Dhabi (DoH), the regulator of the healthcare sector in the Emirate, ...
RDP Pharma AG, a Swiss biotechnology company focused on next-generation protein degradation therapeutics, and the Experi...
Portal Biotech, a pioneering biotechnology company headquartered in London, has secured $35 million in Series A funding,...
Swedish biotech firm Sprint Bioscience has entered a research collaboration with the Experimental Drug Development Cen...
Scientists at the National University of Singapore (NUS Medicine)'s Yong Loo Lin School of Medicine have found proteins ...
A new lab-grown material has revealed that some of the effects of ageing in the heart may be slowed and even reversed. T...
A research team led by Dr Der-Yang Cho, Superintendent of China Medical University Hospital (Taiwan), in collaboration w...
A research team led by Associate Professor Yoshinori Yoshida and Specially Appointed Assistant Professor Yuya ...
Fujirebio, a leading innovator in in-vitro diagnostics, has announced a collaboration with Stanford Medicine, ...
In an era where precision health tech approaches are transforming clinical practice, nephrology has evolved at an unprec...
Japan-headquartered Fujifilm Corporation's Life Sciences Group companies, a portfolio of businesses offering products, s...
The Experimental Drug Development Centre (EDDC), Singapore’s national platform for drug discovery and development,...
Taxis Pharmaceuticals, a US-based clinical stage company at the forefront of developing therapies to treat multidrug-res...
Taiwan’s National Biotechnology Research Park (NBRP) hosted the 2025 Antibody Therapeutic & Frontiers in Biome...
XellSmart Biopharmaceutical (Suzhou/Shanghai) Co., Ltd. announced that the National Medical Product Administration (NM...
Researchers from the Critical Analytics for Manufacturing Personalized-Medicine (CAMP) and Antimicrobial ...
Alloy Therapeutics Inc., a US-based biotechnology ecosystem company, has recently opened its first location in Japa...
Rznomics Inc., a South Korea-based biopharmaceutical startup specialising in RNA-based therapeutics, has entered in...
Patients with non-proliferative diabetic retinopathy (NPDR) currently face a therapeutic gap—one that often leaves...
Agilent Technologies Inc. has signed a Memorandum of Understanding (MoU) with Ubix Therapeutics to accelerate highly tar...
Researchers at Korea Advanced Institute of Science and Technology (KAIST) have successfully developed a novel ...
The Heinz College of Information Systems and Public Policy, in the US, will work with the National University of Singapo...
The University of Queensland (UQ) in Australia will host a $238 million industry-led research centre to accelerate indus...
Sequential Skin Ltd, a world leader in skin microbiome testing, and AMILI, a leading expert in gut microbiome science, h...
The Department of Health - Abu Dhabi (DoH), the regulator of the healthcare sector in the Emirate, in partnership with P...
Singapore HSA has approved, Astellas Pharma Inc. VYLOY™ (zolbetuximab), an anti-claudin 18.2 (CLDN18.2) monoclonal...
ACRO Biomedical Co. has announced that its ABCcolla Collagen Ophthalmic Matrix has received regulatory ap...
Lucence, a Singaporean precision oncology company, and Hong Kong Precision Oncology Society (HKPOS) are embarking i...
Researchers from the A*STAR Genome Institute of Singapore (A*STAR GIS), together with collaborators from South Korea, Ja...
Sarthak Ranade, Area Managing Director, Southeast Asia & India, Johnson & Johnson Innovative Medicine ...
Diabetic wounds often lead to severe complications that can result in amputations. These chronic and non-healing wounds ...
University of Queensland researchers are designing nanotechnology they believe could improve how we treat the most aggre...
Dr. Shaun Lim Wen Zheng, the Field Application Scientist (APAC) at Cytiva (Left); Krishna Karnati, the General...
The regenerative medicine industry is expanding at an undeniably rapid clip. Advances in cell and gene technologies, tis...
Underscoring the critical role of sleep in diabetes prevention, investigators from the Global Centre for Asian Women&rsq...
Identifying therapeutic gene targets is essential for advancing personalised medicine and addressing the genetic basis o...
US-based biotech firm Indaptus Therapeutics, Inc. has secured new patent approvals in China, Japan and Israel for its De...
Callio Therapeutics, a Singapore and US-based biotechnology startup focused on realising the promise of multi-payload an...
A peer-reviewed paper detailing the experimental cancer treatment developed by Professor Georgina Long AO, Universi...
Which products are currently under development? 2025 will be a defining year for Caliway as we push ahead with key clin...
Japan-headquartered pharmaceutical firm Eisai has entered into an exclusive license agreement with a subsidiary of SciCl...
US-based startup HBM Alpha Therapeutics (HBMAT), Inc., an innovative biotechnology company incubated by China-based Harb...
Israel-based CollPlant Biotechnologies, a regenerative and aesthetics medicine company developing innovative technologie...
Researchers from the National University of Singapore (NUS) have pioneered a new catalytic transformation that converts ...
Andelyn Biosciences, Inc., a leading and patient-focused cell and gene therapy Contract Development and Manufactur...
Scientists at the Yong Loo Lin School of Medicine, National University of Singapore (NUS Medicine) have developed a grou...
Sequential Skin, a world leader in skin microbiome testing, and AMILI, a leading expert in gut microbiome science, have ...
A new breast cancer therapy shown to significantly reduce the risk of cancer recurrence and improve disease-free surviva...
India-based Zydus Lifesciences (including its subsidiaries and affiliates), has signed an exclusive development, licensi...
In a breakthrough for the advanced study of gut health, scientists at the National University of Singapore (NUS) have de...
The first clinical consensus statement for managing multiple sclerosis (MS) in Australia and New Zealand has been releas...
LG AI Research recently signed a joint research agreement at the Global Lounge of LG Science Park in Magok, Gangseo-gu,&...
Gene Solutions (GS), a pioneer genomic testing company in South-East Asia, aims to introduce a smart blood test to ...
By partnering with Kyoto University in Japan, China Medical University (CMU) and Healthcare System in Taiwan has es...
The Australian Government is investing close to $20 million in funding for researchers to support groundbreaking nationa...
Japan's Chugai Pharmaceutical Co. has signed a collaboration agreement with GSK's Global Health Unit (GSK GH) for&n...
AB2 Bio, a biotechnology company developing innovative therapies for the treatment of severe systemic hyperinflammatory ...
A team of researchers from National University of Singapore (NUS) has developed a novel method to enhance the precision ...
Asia is emerging as a hub for biopharmaceuticals and vaccine manufacturing, leveraging its strengths in manufacturing an...
Dr Ravindran Kanesvaran, Chairman and Senior Consultant, Division of Medical Oncology,, National Cancer Centre Singapore...
New Zealand-based University of Auckland-led project plans to develop a tool to predict the risk and mitigate the effect...
Researchers from the Yong Loo Lin School of Medicine, National University of Singapore (NUS Medicine) have made a discov...
The Chinese University of Hong Kong (CUHK)’s Faculty of Medicine (CU Medicine) used an artificial intelligence (AI...
etherna immunotherapies NV (“etherna”), a technology platform leader pioneering mRNA and lipid-based nanopar...
The Department of Health – Abu Dhabi (DoH), the regulator of the healthcare sector in the Emirate, in partnership ...
Researchers at the National University of Singapore (NUS) have developed a non-invasive method to improve the effectiven...
